{"symbol": "ABUS", "companyName": "Arbutus Biopharma Corporation", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.arbutusbio.com", "description": "Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.", "CEO": "Mark Murray", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}